These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8488155)

  • 21. [Serum testosterone, dihydrotestosterone, luteinizing hormone and follicle-stimulating hormone versus prostate specific antigen in patients with localized prostate adenocarcinoma who underwent radical prostatectomy. Radioimmunoassays measurements].
    Bantis A; Zissimopoulos A; Athanasiadou P; Gonidi M; Agelonidou E; Strataki A; Matthaios D; Tsartsarakis A
    Hell J Nucl Med; 2007; 10(1):56-61. PubMed ID: 17450256
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective control of rat granulosa cell inhibin production by FSH and LH in vitro.
    Zhang Z; Lee VW; Carson RS; Burger HG
    Mol Cell Endocrinol; 1988 Mar; 56(1-2):35-40. PubMed ID: 3131168
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prostate secretory protein (PSP94) suppresses the growth of androgen-independent prostate cancer cell line (PC3) and xenografts by inducing apoptosis.
    Garde SV; Basrur VS; Li L; Finkelman MA; Krishan A; Wellham L; Ben-Josef E; Haddad M; Taylor JD; Porter AT; Tang DG
    Prostate; 1999 Feb; 38(2):118-25. PubMed ID: 9973097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Destruction of testicular Leydig cells reveals a role of endogenous inhibin in regulating follicle-stimulating hormone secretion in the adult male rat.
    Culler MD; Negro-Vilar A
    Mol Cell Endocrinol; 1990 Mar; 70(1):89-98. PubMed ID: 2160385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of prostate cancer growth by vinblastine and tamoxifen.
    Pienta KJ; Replogle T; Lehr JE
    Prostate; 1995 May; 26(5):270-4. PubMed ID: 7753712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circulating levels of inhibin, prolactin, TSH, LH, and FSH in benign prostatic hypertrophy before and after tumor resection.
    Phadke MA; Vanage GR; Sheth AR
    Prostate; 1987; 10(2):115-22. PubMed ID: 2436203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibin suppresses luteinizing hormone (LH)-releasing hormone self-priming: direct action on follicle-stimulating hormone secretion and opposition of estradiol-enhanced LH secretion.
    Culler MD
    Endocrinology; 1992 Mar; 130(3):1605-14. PubMed ID: 1537310
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Advancing perspectives on prostate cancer: multihormonal influences in pathogenesis.
    Porter A; Ben-Josef E; Crawford ED; Garde S; Huhtaniemi I; Pontes JE
    Mol Urol; 2001; 5(4):181-8. PubMed ID: 11790281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. An inverse relationship exists between seminal plasma inhibin and serum follicle-stimulating hormone in man.
    Scott RS; Burger HG
    J Clin Endocrinol Metab; 1981 Apr; 52(4):796-803. PubMed ID: 6782118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interrelationship between the actions of testosterone and primate Sertoli cell inhibin in the control of gonadotropin secretion by cultured pituitary cells.
    Kitahara S; Kotsuji F; Keeping HS; Oshima H; Troen P; Winters SJ
    Endocrinology; 1991 Feb; 128(2):710-6. PubMed ID: 1899219
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibin A and inhibin B in women with polycystic ovarian syndrome during treatment with FSH to induce mono-ovulation.
    Anderson RA; Groome NP; Baird DT
    Clin Endocrinol (Oxf); 1998 May; 48(5):577-84. PubMed ID: 9666869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hormonal modulation of invitro biosynthesis of inhibin like peptide by human prostate.
    Vanage GR; Phadke MA; Bandivdekar AH; Sheth AR
    Andrologia; 1990; 22(1):7-11. PubMed ID: 2126421
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
    Chang CJ; Ghosh PK; Hu YF; Brueggemeier RW; Lin YC
    Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of continuous inhibin administration on gonadotropin secretion and subunit gene expression in immature and adult male rats.
    Winters SJ; Pohl CR; Adedoyin A; Marshall GR
    Biol Reprod; 1996 Dec; 55(6):1377-82. PubMed ID: 8949896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonists of bombesin/gastrin-releasing peptides as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer.
    Pinski J; Halmos G; Szepeshazi K; Schally AV
    Cancer; 1993 Dec; 72(11):3263-70. PubMed ID: 8242552
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of oestrogen treatment on serum gonadotrophin bioactivity, immunoreactivity and isohormone distribution, and on immunoreactive inhibin levels, in prostatic cancer patients.
    Matikainen T; Haavisto AM; Permi J; de Kretser D; Huhtaniemi I
    Clin Endocrinol (Oxf); 1994 Jun; 40(6):743-50. PubMed ID: 8033364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral cyclophosphamide and oral hydroxyurea in the treatment of hormone refractory prostate cancer in rats.
    Naik H; Lehr J; Akhtar A; Pienta K
    Anticancer Res; 1994; 14(6B):2681-4. PubMed ID: 7872701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prostate inhibin peptide (PIP) in prostate cancer: a comparative immunohistochemical study with prostate-specific antigen (PSA) and prostatic acid phosphatase (PAP).
    Garde SV; Sheth AR; Venkatesan VM; Panchal CJ; Porter AT; Grignon DJ
    Cancer Lett; 1994 Apr; 78(1-3):11-7. PubMed ID: 7514089
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The correlation between pretreatment serum hormone levels and treatment outcome for patients with prostatic cancer and bony metastasis.
    Chen SS; Chen KK; Lin AT; Chang YH; Wu HH; Chang LS
    BJU Int; 2002 May; 89(7):710-3. PubMed ID: 11966629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should we follow-up serum testosterone in patients with advanced prostate cancer?
    Perachino M
    Expert Rev Anticancer Ther; 2010 Jul; 10(7):1031-5. PubMed ID: 20645692
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.